PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
about
Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma.Comprehensive bioinformatics analysis of the mRNA profile of PLCE1 knockdown in esophageal squamous cell carcinoma.The myocardin-related transcription factor MKL co-regulates the cellular levels of two profilin isoforms.Comprehensive bioinformation analysis of the miRNA of PLCE1 knockdown in esophageal squamous cell carcinoma.Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma.Low expression level of ASK1-interacting protein-1 correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer
P2860
PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PFN2, a novel marker of unfavo ...... ageal squamous cell carcinoma.
@en
type
label
PFN2, a novel marker of unfavo ...... ageal squamous cell carcinoma.
@en
prefLabel
PFN2, a novel marker of unfavo ...... ageal squamous cell carcinoma.
@en
P2093
P2860
P1476
PFN2, a novel marker of unfavo ...... ageal squamous cell carcinoma.
@en
P2093
Chun-Xia Liu
Hong-Wei Dang
Jian-Ming Hu
Jin-Fang Jiang
Liang-Hai Wang
Shu-Mao Zhang
Wei-Hua Liang
P2860
P2888
P356
10.1186/S12967-016-0884-Y
P577
2016-05-17T00:00:00Z